VYVANSE

Phase III pivotal results presented of VYVANSE to treat ADHD in adults

WASHINGTON, May 8 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today presented the results of a phase III pivotal study in which VYVANSE demonstrated significant improvements in Attention Deficit Hyperactivity Disorder (ADHD) sympto...

Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track

BASINGSTOKE, England and PHILADELPHIA, November 1 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) the global specialty biopharmaceutical company announces results for the third quarter 2007. Q3 2007 Financial Highlights - Product sales up 41% to $543.1 million; - Tot...

FDA approves additional dosage strengths of Vyvanse

PHILADELPHIA January 3, 2008 Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for three additional dosage strengths for the attention deficit hyperactivity...

VYVANSE CII provided significant efficacy at 14 hours in adults with ADHD

...announced results from a Phase 3b study that found vyvanse (lisdexamfetamine dimesylate) CII demonstrated sig... Attention Deficit Hyperactivity Disorder (ADHD). vyvanse is the first approved stimulant for adults with AD...al Drug Evaluation Unit meeting in Hollywood, FL. vyvanse is currently approved by the US Food and Drug Admi...

Shire to Present New Scientific Data on its ADHD Treatments at a National Scientific Meeting of Psychiatrists on May 18

...ms Poster Presentation #NR2-060 About vyvanse vyvanse is indicated for the treatment of ADHD. Efficacy ...d 6 to 12 and one controlled trial in adults. vyvanse should not be taken by patients who have advanced ...

Physicians Express Continued Need for Safe and Effective Nonstimulant Therapies in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder

... Current and Emerging Drugs Will Not Surpass vyvanse as the Clinical Gold Standard, According to a New Report From Decision Resources WALTHAM, Mass., Jan. 8 /PRNewswire/ -- Decision Resources, one o...

VYVANSE provided behavior, inattention and math test score improvements in children with ADHD

...der (ADHD). In this study, researchers found that vyvanse controlled ADHD symptoms from the first time point...Medicine in Las Vegas. "In this study, once-daily vyvanse significantly improved attention and behavior at 1... the results of a previous clinical trial in which vyvanse demonstrated ADHD symptom control throughout a 12-...

Cadient Group Continues Winning Streak; Receives Multiple Honors at 2008 Pharmaceutical Advertising and Marketing Excellence Awards

...Introduction Cadient Group was recognized with the silver award in the Best New Product Introduction category for its work on Shire US, Inc.'s vyvanse (lisdexamfetamine dimesylate) launch campaign -- Silver Award -- Best Interactive Consumer Campaign Cadient Group and Novartis Vaccines' Flu...

FDA approves VYVANSE, first and only once-daily prodrug stimulant to treat ADHD in adults

...om the U.S. Food and Drug Administration (FDA) for vyvanse (lisdexamfetamine dimesylate), for the treatment o...ight months of availability, more than one million vyvanse prescriptions have been filled. We are very ple...ts by significantly improving their ADHD symptoms. vyvanse has been well accepted by the medical community. ...

VYVANSE trial in adult ADHD demonstrated significant efficacy within 1 week of daily treatment

...ntrol within one week of treatment with once-daily vyvanse (lisdexamfetamine dimesylate), the first prodrug s...ADHD. The results of this study demonstrated that vyvanse significantly improved the core symptoms of ADHD i... in 414 adults aged 18 to 55 years, treatment with vyvanse at all doses studied (30 mg, 50 mg, 70 mg) was sig...

VYVANSE in Medical Technology

New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI)

PHILADELPHIA, May 22 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, announced results of a study showing that coadministration of the ADHD medication VYVANSE(R) (lisdexamfetamine dimesylate) CII with the proton pump inhibitor (PP...

Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration

Published Results Also Show Potentially Differentiating Pharmacokinetic Profile of Prodrug Stimulant PHILADELPHIA, Nov. 29 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY, TSX: SHQ), the global specialty biopharmaceutical company, today announced that Biologic...

Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)

...duct, in territories outside of the United States. vyvanse is approved in the US for the treatment of ADHD in...vioural modification, and medication. About vyvanse Tell the doctor about any heart conditions,...t problems, such as chest pain or fainting. vyvanse should not be taken if you or your child has advan...

Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD

... vyvanse is the first oral ADHD stimulant medication with p...rder (ADHD). In this study, researchers found that vyvanse controlled ADHD symptoms from the first time point... Medicine in Las Vegas. "In this study, once-daily vyvanse significantly improved attention and behavior at 1...

Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD

... In a clinical study of adults, vyvanse taken once-daily significantly improved the sympto...he Journal of Clinical Psychiatry found once-daily vyvanse significantly improved Attention Deficit Hyperacti...val in April 2008 of VYVANSE for adults with ADHD. vyvanse was introduced in July 2007 for the treatment of A...

Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists

... vyvanse demonstrated significant improvement in ADHD sympt...lts aged 18 to 55 years showed that treatment with vyvanse at all doses studied (30 mg, 50 mg, 70 mg) provide...throughout the full treatment period. At endpoint, vyvanse demonstrated a significant improvement in ADHD sym...

Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting

... Analysis of study showed effect size of vyvanse ranged from 1.39 to 1.73 BOSTON, Oct. 26 /PRNews...stablished. "I'm encouraged that in our analysis, vyvanse showed a large effect size," said Stephen Faraone,...e analysis. "This further supports our belief that vyvanse is an effective treatment option for children with...

Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting

... All Doses of vyvanse Studied Demonstrated Significant Efficacy Within O... in 414 adults aged 18 to 55 years, treatment with vyvanse at all doses studied (30 mg, 50 mg, 70 mg) was sig...rved in the first week of the study. All doses of vyvanse showed significant improvements in the average cha...

Shire to Present New Scientific Data on ADHD Treatment Portfolio at APA Annual Meeting

...have taken place at the APA annual meeting. vyvanse (lisdexamfetamine dimesylate): May 23, 2007;...activity Disorder APA Poster# NR658 About vyvanse and ADDERALL XR vyvanse or ADDERALL XR should not be taken by patients who...

12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA (methylphenidate transdermal system)

...target="_blank" href= "http://www.daytrana.com/">www.DAYTRANA.com . About vyvanse and ADDERALL XR vyvanse or ADDERALL XR should not be taken by patients who have advanced arterioscl...

VYVANSE in Medical Dictionary

Stimulants

... to as "uppers" because they increase or speed up ... There are both legal and illegal stimulants . ... Learn about the prescription medication vyvanse (Lisdexamfetamine Dimesylate), drug uses, dosage, side effects, drug ... Stimulants are not intended for use ... Stimulant drugs are drugs...

VYVANSE in Biological Technology

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

...inical trials to assess the efficacy and safety of vyvanse in non ADHD ("Attention Deficit Hyperactivity Diso...he quarter. We are pleased with the performance of vyvanse as it has retained market share during the histori...ting the benefits of the back to school season for vyvanse and are looking forward to increased sales momentu...

Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at 13 Hours After Administration

...s pediatric analog classroom study, treatment with vyvanse was associated with significant improvement in beh...homework and family time may want to consider this vyvanse study data."( ) On May 22, 2009, the US F...proved a change to the prescribing information for vyvanse to include supplemental data that demonstrated sig...

Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment

... vyvanse is the first stimulant to establish duration of ef... Attention Deficit Hyperactivity Disorder (ADHD). vyvanse is the first approved stimulant for adults with AD...al Drug Evaluation Unit meeting in Hollywood, FL. vyvanse is currently approved by the US Food and Drug Admi...

FDA Approves Labeling Change for VYVANSE(R) (lisdexamfetamine dimesylate) CII to Include Supplementary Clinical Data Supporting Efficacy at 13 Hours Postdose in Children Aged 6 to 12 with ADHD

...on Deficit Hyperactivity Disorder (ADHD) treatment vyvanse (R) (lisdexamfetamine dimesylate) CII, to include...t measured (1.5 hours) through 13 hours postdose. vyvanse is now the first and only oral ADHD stimulant trea...re. "The FDA approval of this labeling change for vyvanse provides important additional information for phys...

Shire begins the year with a strong performance

... the recently announced co-promotion agreement for vyvanse in the US. We are continuing to progress our R&...lion, driven by strong growth in: - vyvanse (up 114% to $117 million); - LIALDA/MEZAVA... effort for VYVANSE. - By April 17, 2009 vyvanse had achieved a US ADHD market share of 11.9%...

Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD

...each and frequency of the current sales effort for vyvanse by adding over 600 sales representatives from GSK ...armaceuticals business. "Since its launch in 2007, vyvanse has become the fastest-growing, once-daily, prescr... CNS and Primary Care sales teams in the industry, vyvanse will be introduced to over 70,000 new physicians. ...

Publication of Shire plc's Annual Report 2008

...ions. Any decrease in the combined sales of vyvanse and ADDERALL XR will significantly reduce revenues...and earnings In 2008, the combined sales of vyvanse and ADDERALL XR were $1,420.6 million, representin...ANSE. Other factors that could impact the sales of vyvanse or ADDERALL XR include, but are not limited to: ...

Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion

...n following the strong growth of: - vyvanse (up 317% to $319 million); - LIALDA/MEZAV... to $270 million including strong growth for vyvanse (up 57% to $103 million); - Sales of ADDERALL ...itiated during the third quarter of 2009. vyvanse - for use in the treatment of attention deficit an...

Shire's New Product Portfolio Delivers Strong Quarterly Performance

...of variables that would impact the sales growth of vyvanse during the second half of the year and beyond. We ...leased with the consistent market share gains that vyvanse has achieved in the third quarter and during the s...d on current sales trends we now believe that 2008 vyvanse net sales will be in the range of current publishe...

Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program

...modification, and medication. About VYVANSE(R) vyvanse is indicated for the treatment of ADHD. Efficacy b... heart problems, such as chest pain or fainting. vyvanse should not be taken if you or your child has advan... the last 14 days. Tell the doctor before taking vyvanse if you or your child is being treated for or has s...